"Neoadjuvant therapy” refers to supplemental cancer treatment you receive before your primary treatment. Adjuvant therapies, ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

September is recognized as Ovarian Cancer Awareness Month. But, do you know the signs and symptoms that could be impacting ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in ...

LIPID inCode tests patients to identify familial hypercholesterolemia and prevent cardiovascular diseaseOXFORD, ENGLAND / ACCESSWIRE / September ...

Each September, glo pays tribute to our magazine’s namesake, Gloria Baumgartner, who lost her fight with ovarian cancer in 2008.

BARCELONA, Spain — In a groundbreaking study that could reshape our understanding of cancer, scientists have uncovered a treasure trove of potential new targets for cancer treatment. This discovery ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Research has found 78% of women in the UK do not know the signs and symptoms of the five gynaecological cancers.

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

(Alliance News) - GENinCode PLC on Friday announced its collaboration with The Family Heart Foundation, the University of Texas Southwestern Medical Centre and more to identify and diagnose ...